Patents by Inventor Abdallah SOUABNI

Abdallah SOUABNI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12146000
    Abstract: This invention relates to binding molecules that bind specifically to CD137 and FAP and their use in medicine, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of cancer.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: November 19, 2024
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Eric Borges, Pankaj Gupta, Daniel Christopher Rowe, Justin M. Scheer, Abdallah Souabni, Inigo Tirapu, Joseph Ronald Tumang
  • Patent number: 11999800
    Abstract: This invention relates to binding molecules that bind specifically to CD137 and FAP and their use in medicine, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of cancer.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: June 4, 2024
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Eric Borges, Pankaj Gupta, Daniel Christopher Rowe, Justin M. Scheer, Abdallah Souabni, Inigo Tirapu, Joseph Ronald Tumang
  • Publication number: 20210363273
    Abstract: This invention relates to binding molecules that bind specifically to CD137 and FAP and their use in medicine, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of cancer.
    Type: Application
    Filed: May 18, 2021
    Publication date: November 25, 2021
    Inventors: Eric BORGES, Pankaj GUPTA, Daniel Christopher ROWE, Justin M. SCHEER, Abdallah SOUABNI, Inigo TIRAPU, Joseph Ronald TUMANG